Paden brings to this position over 20 years of diverse experience in clinical research, including operational and scientific leadership roles, clinical trial management and monitoring, publication planning, product lifecycle management, and clinical training and education.
At Prometrika, Paden will lead clinical operations in day-to-day trial management activities and in the development of systems and procedures to further enhance the company's delivery of clinical research.
Paden's leadership roles have included head of clinical development operations at ContraFect Corp., senior consultant at Halloran Consulting, and director of clinical development medical affairs at Boehringer Ingelheim Pharmaceuticals.
Her work has covered orphan indications in oncology, cardiovascular disease, and genetic disorders.
Founded in 2003 and based in Cambridge, Massachusetts, Prometrika utilises a collaborative approach to clinical development and execution with a close-knit, highly-experienced senior leadership team involved in all phases of trials.
Prometrika's services include complete clinical operations and clinical trial management, data management, pharmacovigilance, biostatistics and programming, medical writing, and regulatory submissions.
EDX Medical to provide molecular profiling services to Astron Health
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees